Guided Therapeutics, Inc. and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva® Advanced Cervical Scan
7/2/2013 8:33:39 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) and its Turkish distributor, I.T.E.M. Medical Technologies Group, today announced a major program for early detection and prevention of cervical cancer involving Guided Therapeutics’ LuViva® Advanced Cervical Scan. The program for 2013 and 2014, to be funded by Turkey’s Ministry of Health, would involve the order and placement of up to $3 million worth of LuViva Advanced Cervical Scan devices and associated disposables. In addition, the Ministry of Health will conduct clinical trials to assess the utility of LuViva within a broader national program of cervical cancer control.
Help employers find you! Check out all the jobs and post your resume.
comments powered by